Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial
===============================================================================================================================================================================================================

* David P. Carbone
* Tudor-Eliade Ciuleanu
* Michael Schenker
* Manuel Cobo
* Stéphanie Bordenave
* Oscar Juan-Vidal
* Juliana Menezes
* Niels Reinmuth
* Eduardo Richardet
* Ying Cheng
* Hideaki Mizutani
* Enriqueta Felip
* Bogdan Zurawski
* Aurelia Alexandru
* Luis Paz-Ares
* Shun Lu
* Thomas John
* Xiaoqing Zhang
* Javed Mahmood
* Nan Hu
* Tuli De
* Irene Santi
* John R. Penrod
* Yong Yuan
* Adam Lee
* Martin Reck